Why is Koch Industries and the Chamber Getting Entitlements?

Yesterday it was in the news that Koch Industries, who spent millions of dollars opposing health care reform, applied for federal health care dollars to bolster its early retiree program. Today Healthwatch lists more than a dozen members of the board of directors of the U.S. Chamber of Commerce have also applied for these hated federal funds including Pfizer, PepsiCo, New York Life Insurance Company, Eastman Kodak, IBM, Rolls-Royce North America. This past year the U.S. Chamber of Commerce rolled out $3 million a week to battle President Obama’s major agenda items. Now we find out that the chamber will spend some $75 million trying to unseat Democrats who voted for the health care law all the while its board members profit from it. In other healthcare news, Forbes magazine this week released its first-ever survey of America’s most profitable hospitals, reporting that 24 hospitals with more than 200 beds make 25 cents or more for every dollar of patient revenue they take in. In other words, if you get sick and it costs a million dollars to get you well - not uncommon in today's world, just the corporate hospital's CEO and stockholders will have skimmed off a quarter million bucks. And that doesn't begin to add in the other hundreds of thousands skimmed off by the health insurance banksters, and inflated drug company profits. No wonder Americans pay about twice as much as any other country in the world for healthcare, and executives in that industry are the richest in america.

Popular blog posts

No blog posts. You can add one!

ADHD: Hunter in a Farmer's World

Thom Hartmann has written a dozen books covering ADD / ADHD - Attention Deficit Hyperactive Disorder.

Join Thom for his new twice-weekly email newsletters on ADHD, whether it affects you or a member of your family.

Thom's Blog Is On the Move

Hello All

Thom's blog in this space and moving to a new home.

Please follow us across to hartmannreport.com - this will be the only place going forward to read Thom's blog posts and articles.